awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q49393096-BB661A35-0DB9-43E9-8721-F71036423AD3
Q49393096-BB661A35-0DB9-43E9-8721-F71036423AD3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q49393096-BB661A35-0DB9-43E9-8721-F71036423AD3
Investigational therapies targeting the granulocyte macrophage colony-stimulating factor receptor-α in rheumatoid arthritis: focus on mavrilimumab.
P2860
Q49393096-BB661A35-0DB9-43E9-8721-F71036423AD3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q49393096-BB661A35-0DB9-43E9-8721-F71036423AD3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
019966add03d767ba29b585cd8c0dc5a2008c7c3
P2860
A randomised phase IIb study of mavrilimumab, a novel GM-CSF receptor alpha monoclonal antibody, in the treatment of rheumatoid arthritis.